Search Results - "Bumbier, E E"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats by Walz, D T, Griswold, D E, DiMartino, M J, Bumbier, E E

    Published in Journal of rheumatology (01-11-1980)
    “…Auranofin orally administered to rats resulted in delayed and protracted peak blood and serum gold levels occurring 24 to 48 h post administration. During this…”
    Get more information
    Journal Article
  2. 2

    Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats by Walz, D T, Griswold, D E, DiMartino, M J, Bumbier, E E

    Published in Journal of rheumatology (01-02-1983)
    “…Serum, blood and cell-associated gold were determined at various time periods after intravenous administration of 1 mg Au/kg of auranofin (AF), gold sodium…”
    Get more information
    Journal Article
  3. 3

    Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients by Walz, D T, Griswold, D E, DiMartino, M J, Bumbier, E E

    Published in Journal of rheumatology (01-09-1981)
    “…We examined whether changes in auranofin dose regimen in rheumatoid arthritis (RA) patients affect cell-associated and/or serum gold levels. In 7 RA patients,…”
    Get more information
    Journal Article
  4. 4

    Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form by Caldwell, H C, Westlake, W J, Schriver, R C, Bumbier, E E

    Published in Journal of clinical pharmacology (01-02-1981)
    “…A controlled-release lithium carbonate tablet was compared to an immediate release lithium carbonate capsule in normal volunteers. These crossover studies at…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Distribution of gold in blood following administration of auranofin (SK&F D-39162) by Walz, D T, Griswold, D E, DiMartino, M J, Bumbier, E E

    “…After oral administration of auranofin (SK&F D-39162), a new antiarthritic gold compound, to rats, dogs and humans, a major portion (approximately 50%) of the…”
    Get more information
    Journal Article
  7. 7